- Summary
- Actions
- Committee Votes
- Floor Votes
- Memo
- Text
- LFIN
- Chamber Video/Transcript
A08502 Summary:
| BILL NO | A08502 |
|   | |
| SAME AS | SAME AS S08040 |
|   | |
| SPONSOR | Hunter |
|   | |
| COSPNSR | Gunther, Santabarbara |
|   | |
| MLTSPNSR | |
|   | |
| Amd §§3216, 3221 & 4303, Ins L; amd §365-a, Soc Serv L; amd §5, Chap of 2023 (as proposed in S.1196-A & A.1673-A) | |
|   | |
| Requires health insurance policies and medicaid to cover biomarker precision medical testing for diagnosis, treatment, or appropriate management of, or ongoing monitoring to guide treatment decisions for, a covered person's disease or condition when the test has recognized efficacy and appropriateness for such purposes. | |